Obesity and the risk of Parkinson's disease

被引:87
作者
Chen, HL
Zhang, SMM
Schwarzschild, MA
Hernán, MA
Willett, WC
Ascherio, A
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[6] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA
关键词
body composition; body mass index; obesity; Parkinson disease; prospective studies;
D O I
10.1093/aje/kwh059
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Dopamine is involved in the regulation of food intake, and obese persons have decreased dopamine D2 receptor availability in the striatum. Furthermore, midlife triceps skinfold thickness has been found to be positively associated with the risk of Parkinson's disease (PD) among Japanese-American men in Hawaii. The authors prospectively investigated whether obesity was associated with PD risk in two large cohorts of US men and women. They documented 249 cases of PD in men (1986-2000) and 202 cases in women (1976-1998). Neither baseline body mass index (weight (kg)/height (m)(2)) nor early adult body mass index was associated with PD risk. The multivariate relative risk for a baseline body mass index of greater than or equal to30 versus <23 was 0.8 (95% confidence interval (CI): 0.6, 1.2; p for trend = 0.3). Overall, waist circumference and waist-to-hip ratio were not related to PD risk. However, among never smokers, both variables showed significantly positive associations with PD risk. The relative risks for comparisons of extreme quintiles were 1.9 (95% CI: 1.0, 3.4; p for trend = 0.03) for waist circumference and 2.0 (95% CI: 1.1, 3.6; p for trend = 0.03) for waist-to-hip ratio. The results do not support a role of overall obesity in PD pathogenesis; however, central obesity may be associated with higher PD risk among never smokers, and this finding merits further investigation.
引用
收藏
页码:547 / 555
页数:9
相关论文
共 41 条
[1]  
ABBOTT RA, 1992, EUR J CLIN NUTR, V46, P879
[2]   Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[3]   Caffeine, postmenopausal estrogen, and risk of Parkinson's disease [J].
Ascherio, A ;
Chen, H ;
Schwarzschild, MA ;
Zhang, SM ;
Colditz, GA ;
Speizer, FE .
NEUROLOGY, 2003, 60 (05) :790-795
[4]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[5]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[6]   WEIGHT CHANGE AND BODY-COMPOSITION IN PATIENTS WITH PARKINSONS-DISEASE [J].
BEYER, PL ;
PALARINO, MY ;
MICHALEK, D ;
BUSENBARK, K ;
KOLLER, WC .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1995, 95 (09) :979-983
[7]   Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990 [J].
Bower, JH ;
Maraganore, DM ;
McDonnell, SK ;
Rocca, WA .
NEUROLOGY, 1999, 52 (06) :1214-1220
[8]  
Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158
[9]   INHIBITION OF UPTAKE OF 1-METHYL-4-PHENYLPYRIDINIUM ION AND DOPAMINE IN STRIATAL SYNAPTOSOMES BY TOBACCO-SMOKE COMPONENTS [J].
CARR, LA ;
BASHAM, JK ;
YORK, BK ;
ROWELL, PP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :285-287
[10]   ATTENUATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED NEUROTOXICITY BY TOBACCO-SMOKE [J].
CARR, LA ;
ROWELL, PP .
NEUROPHARMACOLOGY, 1990, 29 (03) :311-314